Multiple sclerosis (MS) is the most common neurological disorder among young adults and often results in a handicap. It is an auto-immune disease in which the body attacks its own tissues. The immune attack in MS targets the central nervous system. The lesions are well-localised and are called “plaques”.
Is a vaccine for MS a possibility in the futur? A pertinent question. Prof C. Sindic provides a hopeful answer.
Every day counts. we need your help to make concrete progress in research into multiple sclerosis possible. Yes, I will finance one day of research
Are MS patients more affected by Covid-19?
Are MS patients given priority in the vaccination plan?
Twice a year, the Charcot Foundation publishes a Bulletin which wants to be the objective reflection of research and last acquisitions in Multiple sclerosis as well in the field of our knowledge of the disease as of the new treatments under study
